KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will present at the Cantor Global Healthcare Conference on Wednesday, September 27th, 2023 at 4:10 p.m. ET in New York, NY. A live webcast of the presentation will be available on the Company’s website at www.kalvista.com. An audio
Click here to view original post